Linguistic validation of the irritable bowel syndrome-quality of life questionnaire for Iranian patients

Acta Medica Iranica

Volumn 49, Issue 6, 2011, Pages 390-395

  Gholamrezaei, Ali ^a,b   Zolfaghari, Behzad ^a   Farajzadegan, Ziba ^a,b   Nemati, Kianoosh ^a   Daghaghzadeh, Hamed ^a,b   Tavakkoli, Hamid ^a,b   Emami, Mohammad Hassan ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Poursina Hakim Research Institute   (Iran)

Author keywords

Irritable bowel syndrome; Quality of life; Reliability; Validity

Indexed keywords

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISCRIMINANT VALIDITY; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNAL CONSISTENCY; IRANIAN; IRRITABLE BOWEL SYNDROME QUALITY OF LIFE QUESTIONNAIRE; IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; TEST RETEST RELIABILITY; VALIDATION PROCESS;

ADULT; ANALYSIS OF VARIANCE; ANXIETY; COMPREHENSION; CULTURAL CHARACTERISTICS; DEPRESSION; FEMALE; HUMANS; IRAN; IRRITABLE BOWEL SYNDROME; LANGUAGE; MALE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80051714091     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130(5):1480-91.
2. Saito YA, Schoenfeld P, Locke GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97(8):1910-15.
3. Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi, A; Solhpour A, Habibi M, Zali M R. Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population. Eur J Gastroenterol Hepatol 2008;20(8):719-25.
4. Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. A cost analysis of functional bowel disorders in Iran. Int J Colorectal Dis 2006;22(7):791-9.
5. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16(6):1171-85.
6. Higginson IJ, Carr AJ. Using quality of life measures in the clinical setting. BMJ 2001;322:1297-1300.
7. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998;43(2):400-11.
8. Drossman DA, Patrick DL, Whitehead WE, Toner B B, Diamant N E, Hu Y, Huanguang Jia H, Bangdiwala Sh I. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000;95(4):999-1007.
9. Patrick DL, Drossman DA, Frederick IO. A Quality-of- Life Measure for Persons with Irritable Bowel Syndrome (IBS-QOL): User's Manual and Scoring Diskette for United States Version. Washington, DC: University of Washington; 1997.
10. Park JM, Choi MG, Oh JH, Cho Y K, Lee I S, Kim S W, Choi K Y, Chung I S. Cross-Cultural Validation of Irritable Bowel Syndrome Quality of Life in Korea. Dig Dis Sci 2006;51(8):1478-84.
11. Huang WW, Zhou FS, Bushnell DM, Diakite C, Yang XH. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire. Qual Life Res 2007;16(6):991-6.
12. Kanazawa M, Drossman DA, Shinozaki M, Sagami Y, Yuka Endo, Palsson O S, Hongo M, Whitehead W E, Fukudo Sh. Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med 2007;1:6.
13. Haghayegh A, Kalantari M, Solati K, Molavi H, Adibi P. Study on Validity of Farsi Version of Irritable Bowel Syndrome Quality of Life Questionnaire (IBS-QOL-34). GOVARESH 2008; 13(2): 99-105.
14. Acquadro C, Conway K, Giroudet C, Mear I. Linguistic validation manual for patient-reported outcomes (PRO) instruments. Lyon: Mapi Research Institute; 2004.
15. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005;8(2):94-104.
16. Gordon S, Ameen V, Bagby B, Shahan B, Jhingran P, Carter E. Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci 2003;48(7):1317-23.
17. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11(2):395-402.
18. Bijkerk CJ, de Wit NJ, Muris JW, Jones RH, Knottnerus JA, Hoes AW. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 2003;98(1):122-7.
19. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes 2003;1(1):14-9.
20. Gholamrezaei A, Nemati K, Emami MH. Which end point is more comprehensive in reflecting changes in irritable bowel syndrome treatment trials? Am J Gastroenterol 2009;104(11):2859
21. Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130(5):1538-51.